[Peripheral hemodynamics in neurocirculatory dystonia]

AIM

To assess the state of peripheral hemodynamics in patients with neurocirculatory dystonia and elucidate its relation to disease duration and clinical presentation.

MATERIAL AND METHODS

Laser doppler flowmetry was used for the study of microcirculation in 25 healthy subjects and 91 patients with neurocirculatory dystonia.

RESULTS

Most healthy subjects (73.7%) had normocirculatory type of microcirculation. Hyperemic type was most frequent (36.7%) in patients with mild neurocirculatory dystonia, while majority (57.4%) of patients with moderate severity and severe neurocirculatory dystonia had congestive-stasical type of microcirculation. Hyperkinetic syndrome predominated in patients with hyperemic type of microcirculation, while hyperventilatory, astenic and asteno-neurotic syndromes were characteristic for those with congestive-stasical type. Moreover patients with congestive-stasical type had longer disease duration.

CONCLUSION

Changes of microcirculation observed in patients with neurocirculatory dystonia evidence for the presence of relationship between clinical signs and disease duration. Patients with congestive-stasical type of microcirculation were characterized by unfavorable course and longer disease duration.

[Blood lipid levels in various forms of ischemic heart disease]

Enzyme assays of major blood lipid parameters detected no differences between peripheral venous blood specimens of normal subjects and functional cardiologic patients, nor between peripheral and central flow specimens of patients with neurocirculatory dystonia. Alpha cholesterol was typically decreased in all types of coronary disease, the decrease being particularly marked in central cardiac flow. Chronic coronary disease is associated with a rise of total cholesterol, its atherogenic fractions, the atherogenic coefficient and blood triglycerides, as compared to the respective parameters of functional cardiac patients. Acute and subacute coronary disease is associated with decreased blood lipid values, as compared to chronic coronary disease. Blood lipid phenotyping and secondary preventive procedures should rather be done in the absence of aggravations.